Venous thromboembolism after esophagectomy for cancer: a systematic review of the literature to evaluate incidence, risk factors, and prophylaxis.
Nikoletta A TheochariChristina A TheochariDamianos G KokkinidisAristotelis KechagiasOrestis LyrosStefanos GiannopoulosStyliani MantziariDimitrios SchizasPublished in: Surgery today (2021)
Despite advances in perioperative care, VTE after esophagectomy still represents a source of morbidity for about 4% of patients. Low molecular weight heparin is suggested as the routine standard prophylactic regimen after esophageal cancer surgery.
Keyphrases
- venous thromboembolism
- risk factors
- end stage renal disease
- direct oral anticoagulants
- ejection fraction
- healthcare
- newly diagnosed
- chronic kidney disease
- minimally invasive
- palliative care
- prognostic factors
- peritoneal dialysis
- papillary thyroid
- patients undergoing
- cardiac surgery
- coronary artery bypass
- squamous cell carcinoma
- acute kidney injury
- atrial fibrillation
- young adults
- growth factor
- squamous cell